Alnylam Pharmaceuticals, Inc. (ALNY) was a big mover last session, as the company saw its shares rise almost 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $71.95 to $80.50 in the past one-month time frame.
The company has seen 1 positive estimate revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead for Alnylam. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Alnylam currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Some well-performing stocks in the medical sector include Emergent BioSolutions, Inc. (EBS), Epizyme, Inc. (EPZM) and Fibrocell Science, Inc. (FCSC). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment